Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2024. Start Trial.
Date Value
September 30, 2026 -18.72M
June 30, 2026 -22.22M
March 31, 2026 -21.84M
December 31, 2025 -16.63M
September 30, 2025 -15.23M
June 30, 2025 -18.15M
Date Value
March 31, 2025 -16.29M
December 31, 2024 -11.78M
September 30, 2024 -17.69M
June 30, 2024 -10.14M
March 31, 2024 -13.18M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Capricor Therapeutics, Inc. -35.69M
ARS Pharmaceuticals, Inc. -33.71M
Ardelyx, Inc. 2.171M
Compass Therapeutics, Inc. -16.32M
ACADIA Pharmaceuticals, Inc. 11.50M